Table 2.
Sample in MNA-SF analysis |
||||||
---|---|---|---|---|---|---|
A. COVID-19 |
B. Non-COVID-19 |
|||||
All | Died | Survived | All | Died | Survived | |
n (%) | 1297 (100) | 145 (11.2) | 1152 (88.8) | 6942 (100) | 85 (1.2) | 6857 (98.8) |
Age, median (IQR) | 83 (12) | 88 (11) | 83 (12) | 84 (12) | 90 (10) | 84 (11) |
Men, n (%) | 592 (45.6) | 79 (54.5) | 513 (44.5) | 2746 (39.6) | 41 (48.2) | 2705 (39.5) |
MNA-SF score, median (IQR) | 9 (4) | 8 (4) | 9 (4) | 9 (3) | 7 (4) | 9 (3) |
MNA-SF score, categorised | ||||||
Normal: 12–14, n (%) | 227 (17.5) | 19 (13.1) | 208 (18.1) | 1612 (23.2) | 6 (7.06) | 1606 (23.4) |
At risk: 8–11, n (%) | 690 (53.2) | 59 (40.7) | 631 (54.8) | 3634 (52.4) | 29 (34.1) | 3605 (52.6) |
Malnourished: 0–7, n (%) | 380 (29.3) | 67 (46.2) | 313 (27.2) | 1696 (24.4) | 50 (58.8) | 1646 (24.0) |
Number of diseases, median (IQR, Min, Max) | 6 (3,1,24) | 7 (2,3,14) | 6 (2,1,24) | 5 (2,1,17) | 6 (2,1,14) | 5 (2,1,17) |
CCI, median (IQR, Min, Max) | 1 (2,0,9) | 2 (2,0,7) | 1 (2,0,9) | 1 (2,0,9) | 2 (2,0,8) | 1 (2,0,9) |
HFRS, median (IQR, Min, Max) | 1 (1,0,8) | 2 (1,0,8) | 1 (1,0,8) | 2 (1,0,12) | 2 (2,0,6) | 2 (1,0,12) |
Number of drugs, median (IQR, Min, Max) | 10 (7,1,33) | 11 (7,1,33) | 10 (7,1,29) | 9 (6,1,40) | 11 (7,1,24) | 9 (6,1,40) |
1st wave: prior to September 1st 2020, n (% within the 1st wave) | 818 (100) | 104 (12.7) | 714 (87.3) | 4501 (100) | 61 (1.4) | 4440 (98.6) |
2nd wave: after September 1st 2020, n (% within the 2nd wave) | 479 (100) | 41 (8.6) | 438 (91.4) | 2441 (100) | 24 (1.0) | 2417 (99.0) |
Abbreviations: CCI = Charlson comorbidity index, HFRS = Hospital Frailty Risk Score, IQR = interquartile range, MNA-SF = Mini Nutritional Assessment Short Form.